Dexcom announced today that it entered into a strategic partnership with Oura, maker of leading smart ring technology.

Medtronic announced today that it received FDA clearance for its new InPen insulin delivery system application.

Abbott modified its original FreeStyle Libre 2 for the purpose of integration with automated insulin delivery systems. It ...

Medtronic (NYSE:MDT) has plans to submit its MiniMed 780G for an expanded indication from the FDA for type 2 diabetes in the near future.

Abbott announced today that it officially opened a new state-of-the-art manufacturing facility in Kilkenny, Ireland.